Fig. 5

Number and type of all pharmacist medicines recommendations and implementation rates at six month follow-up. HbA1c, glycated haemoglobin; IR, immediate release; MR, modified release; NOAC, non-vitamin K antagonist oral anticoagulant; VKA, vitamin K antagonist. *two ABC-specific recommendations for one resident to (1) review diltiazem and bisoprolol in a resident with heart failure and then (2) review antihypertensive medications accordingly (readings > 140/85 mmHg), two non-ABC specific recommendations to rationalise bendroflumethiazide/perindopril in a resident with hypotension, and rationalise linagliptin in a diabetic resident with a HbA1c of 42 mmol/mol. **one ABC-specific recommendation to repeat HbA1c in a resident with documented history of type 2 diabetes but no record of blood glucose levels, HbA1c or prescription of antidiabetic medicines, one non-ABC specific recommendation to repeat HbA1c in a resident with type 2 diabetes who had gliclazide stopped with no repeat HbA1c. ***ABC-specific recommendation for a resident on warfarin with time in therapeutic range < 70%